Read More

Danimer Scientific’s CEO And Chairman Steve Croskrey Announces Retirement, To Step Down As CEO No Later Than The End Of This Calendar Year; To Exit Chairman Position May 20, 2024; Board Appoints Richard J. Hendrix As Interim CEO And New Co Chairman

Danimer Scientific, Inc. (NYSE:DNMR) ("Danimer" or the "Company"), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today that Stephen E.

DNMR

Read More

Helius Medical Technologies’ PoNS Now Available On The VA Federal Supply Schedule And General Services Administration Advantage Contracts; PoNS System, Item # S1-001-02, Priced At $23,843.72 And The PoNS Mouthpiece, Item # M1-001, Priced At $7,344.97

-- Approval provides U.S. veterans and other U.S. government agency employees who suffer gait and balance impairment due to multiple sclerosis (MS) access to the only portable neurostimulation therapy with the potential

HSDT